Showing results (1371-1380 of 1,422) with videos related to

Sort By:
Pageof 143
World Journal of Pediatrics : WJP|December 23, 2022
Early recombinant human growth hormone treatment improves mental development and alleviates deterioration of motor function in infants and young children with Prader-Willi syndromeRuo-Qian Cheng, Yan-Qin Ying, Zheng-Qing Qiu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 11, 2025
Effectiveness and Safety of Oral Azvudine for Elderly Hospitalized Patients With COVID-19: A Multicenter, Retrospective, Real-World StudyRanran Sun, Haiyu Wang, Junyi Sun, et al.
Journal of the National Cancer Center|July 22, 2024
Assessment of the expression pattern of HER2 and its correlation with HER2-targeting antibody-drug conjugate therapy in urothelial cancerHuizi Lei, Yun Ling, Pei Yuan, et al.
Frontiers in Microbiology|May 15, 2025
The tongue coating microbiome is perturbed in atrial fibrillation and partly normalized after catheter ablationLing Wang, Na Li, Yuchen Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
Safety, Efficacy, and Biomarker Analysis of Toripalimab in Patients with Previously Treated Advanced Urothelial Carcinoma: Results from a Multicenter Phase II Trial POLARIS-03Xinan Sheng, Haige Chen, Bin Hu, et al.
The Journal of Infection|November 19, 2024
Real-world effectiveness and safety of azvudine in hospitalized patients with SARS-CoV-2 infection: A multicenter, retrospective cohort studyZhigang Ren, Mengzhao Yang, Guanyue Su, et al.
Chinese Medical Journal|July 5, 2026
Age of onset by temporal and spatial changes and prognostic value for esophageal cancerKan Zhong, Xin Song, Xueke Zhao, et al.
National Science Review|October 25, 2021
SNX14 deficiency-induced defective axonal mitochondrial transport in Purkinje cells underlies cerebellar ataxia and can be reversed by valproateHongfeng Zhang, Yujuan Hong, Weijie Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 11, 2022
A Randomized, Open-Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID-19, a Pilot StudyZhigang Ren, Hong Luo, Zujiang Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2023
Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical TrialsXinan Sheng, Lin Wang, Zhisong He, et al.
Pageof 143